Merck & Co., Inc., Rahway, NJ, USA.
Sci Prog. 2024 Jul-Sep;107(3):368504241265182. doi: 10.1177/00368504241265182.
Insights into mechanisms driving either activation or inhibition of immune response are crucial in understanding the pathology of various diseases. The differentiation of viral from endogenous RNA in the cytoplasm by pattern-recognition receptors, such as retinoic acid-inducible gene I (RIG-I), is one of the essential paths for timely activation of an antiviral immune response through induction of type I interferons (IFN). In this mini-review, we describe the most recent developments centered around RIG-I's structure and mechanism of action. We summarize the paradigm-changing work over the past few years that helped us better understand RIG-I's monomeric and oligomerization states and their role in conveying immune response. We also discuss potential applications of the modulation of the RIG-I pathway in preventing autoimmune diseases or induction of immunity against viral infections. Overall, our review aims to summarize innovative research published in the past few years to help clarify questions that have long persisted around RIG-I.
深入了解驱动免疫反应激活或抑制的机制对于理解各种疾病的病理学至关重要。模式识别受体(如视黄酸诱导基因 I(RIG-I))在细胞质中区分病毒和内源性 RNA 是通过诱导 I 型干扰素(IFN)及时激活抗病毒免疫反应的重要途径之一。在这篇迷你综述中,我们描述了围绕 RIG-I 结构和作用机制的最新进展。我们总结了过去几年改变范式的工作,这些工作帮助我们更好地理解了 RIG-I 的单体和寡聚状态及其在传递免疫反应中的作用。我们还讨论了调节 RIG-I 途径在预防自身免疫性疾病或诱导针对病毒感染的免疫方面的潜在应用。总的来说,我们的综述旨在总结过去几年发表的创新性研究,以帮助澄清围绕 RIG-I 长期存在的问题。